Study to Evaluate CCS1477 in Advanced Tumours

Clinical trial NCT03568656 · COMPLETED

Trial details

NCT number: NCT03568656
Sponsor: CellCentric Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostate Cancer Metastatic Breast Cancer Non-small Cell Lung Cancer Advanced Solid Tumors

Start date: 2018-07-23
Primary completion: 2025-07-06
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.